A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis

RATIONALE: Few comparative studies have evaluated the differences between intravenous alendronate (ALN) and ibandronate (IBN) in patients with osteoporosis. This study was to compare the effects of these 2 drugs on bone mineral density (BMD), bone metabolic markers, and adverse events in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Horikawa, Akira, Miyakoshi, Naohisa, Hongo, Michio, Kasukawa, Yuji, Kodama, Hiroyuki, Shimada, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380741/
https://www.ncbi.nlm.nih.gov/pubmed/30732159
http://dx.doi.org/10.1097/MD.0000000000014340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380741/
https://www.ncbi.nlm.nih.gov/pubmed/30732159
http://dx.doi.org/10.1097/MD.0000000000014340

Ejemplares similares